Vis enkel innførsel

dc.contributor.authorRisvoll, Hilde Monica
dc.contributor.authorRisør, Torsten
dc.contributor.authorHalvorsen, Kjell Hermann
dc.contributor.authorWaaseth, Marit
dc.contributor.authorStub, Trine
dc.contributor.authorGiverhaug, Trude
dc.contributor.authorMusial, Frauke
dc.date.accessioned2024-01-02T10:29:31Z
dc.date.available2024-01-02T10:29:31Z
dc.date.issued2023-11-20
dc.description.abstractObjective - The use of dietary supplements (DS) may cause harm through direct and indirect effects. Patients with dementia may be particularly vulnerable. This study aims to explore general practitioners’ (GPs’) experiences with DS use by these patients, the GPs perceived responsibilities, obstacles in taking on this responsibility, their attitudes toward DS, and suggestions for improvements to safeguard the use of DS in this patient group.<p> <p>Design - Qualitative individual interview study conducted February - December 2019. Data were analysed using systematic text condensation.<p> <p>Setting - Primary healthcare clinics in Norway.<p> <p>Subjects - Fourteen Norwegian GPs.<p> <p>Findings - None of the informants were dismissive of patients using DS. They were aware of the possible direct risks and had observed them in patients. Most GPs showed little awareness of potential indirect risks to patients with dementia who use DS. They acknowledged the need for caretaking of these patients. Although there were differences in practice styles, most of the GPs wished to help their patients safeguarding DS use but found it difficult due to the lack of quality assurance of product information. Furthermore, there were no effective ways for the GPs to document DS use in the patients’ records. Several suggestions for improvement were given by the GPs, such as increased attention from GPs, inclusion of DS in the prescription software, and stricter regulatory systems for DS from the authorities.<p> <p>Conclusion - The GPs had initially little awareness of this safety risk, but there were differences in practice style and attitudes towards DS. The GPs did not perceive themselves as main responsible for safe use of DS in patient with dementia. The most important reason to disclaim responsibility was lack of information about the products. One suggestion for improvement was better integration of DS in patients’ medical record.en_US
dc.identifier.citationRisvoll H, Risør T, Halvorsen KH, Waaseth M, Stub T, Giverhaug T, Musial F. General practitioners’ role in safeguarding patients with dementia in their use of dietary supplements. A qualitative study. Scandinavian Journal of Primary Health Care. 2023
dc.identifier.cristinIDFRIDAID 2199395
dc.identifier.doi10.1080/02813432.2023.2283182
dc.identifier.issn0281-3432
dc.identifier.issn1502-7724
dc.identifier.urihttps://hdl.handle.net/10037/32274
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.relation.journalScandinavian Journal of Primary Health Care
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0en_US
dc.rightsAttribution 4.0 International (CC BY 4.0)en_US
dc.titleGeneral practitioners’ role in safeguarding patients with dementia in their use of dietary supplements. A qualitative studyen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution 4.0 International (CC BY 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution 4.0 International (CC BY 4.0)